Portfolio (Quarterly)
Guide ↗
Avidity Partners Management LP
· CIK 0001791827| # | Ticker | Company | Sector | Shares | Value ↓ | % Port | Chg Shares | Chg % | Period Price ① | Since Period ① |
|---|---|---|---|---|---|---|---|---|---|---|
| 41 | — | ANTERIS TECHNOLOGIES GLOBAL | — | 150,000.0 | $832K | 0.17% | NEW | — | $5.55 | — |
| 42 | ABUS | ARBUTUS BIOPHARMA CORP | Healthcare | 125,000.0 | $562K | 0.11% | NEW | — | $4.50 | -5.3% |
| 43 | — | BRIDGEBIO ONCOLOGY THERAPEUTIC | — | 43,853.0 | $392K | 0.08% | NEW | — | $8.95 | — |
| 44 | ACAD | ACADIA PHARM | Healthcare | 12,967.0 | $289K | 0.06% | NEW | — | $22.26 | -5.3% |
| 45 | TRVI | TREVI THERAPEUTICS INC | Healthcare | 6,660.0 | $79K | 0.02% | NEW | — | $11.93 | +19.1% |
① Period Price is the implied market price on the last day of the reporting period, calculated as reported value ÷ shares held. It is not the fund's purchase price or cost basis — the fund may have initiated or added to the position at any point during the quarter at a different price. Since Period shows the price change from that quarter-end snapshot to today's last price — it reflects stock movement after the report date, not the fund's actual return.
Sector Allocation
Healthcare
99.5%
Consumer Defensive
0.4%
Consumer Cyclical
0.2%